Sean-Lin Huang 黃賢驎

Sean-Lin Huang has over 17 years of work experience. Sean-Lin began their career in 2003 as a Software Developer at Trend Micro. In 2004, they moved to IBM as an Advisory Sales Specialist. In 2007, they Co-Founded Ubic Corp., a startup aimed to develop the next generation of online social network in Asia. Sean-Lin formulated financial and strategic plans, sought funding from VCs and private investors in seed round, and built, trained, and led the sales and marketing department. In 2010, Huang moved to Citi as an EMEA Associate. In 2012, they became an AVP at OUE Limited. In 2016, Huang founded and became the CEO of Amwise Diagnostic PTE. LTD. Sean-Lin built up Clinical Research, Lab Operation, Manufacturing, and Sales/Marketing teams in Singapore, Taiwan, and China from scratch, and raised over USD 20 million for Amwise Diagnostics to develop cancer precision medicine. Sean-Lin expanded operations in Taiwan to validate newly developed technology through clinical trials, and set up a research lab in Hangzhou. The company's core technology was officially recognized in Breast Cancer Treatment Guidelines by the Chinese Society of Clinical Oncology and received national level expert consensus via the Chinese Journal of Oncology.

Sean-Lin Huang 黃賢驎 has an extensive education history. Sean-Lin started their education in 1999, earning a Bachelor of Science in Computer Science from National Chiao Tung University in 2003. From 2009 to 2011, they completed an MBA Program at IESE Business School. In 2011, they completed an MBA from China Europe International Business School (CEIBS) through an International Exchange Program. Sean-Lin is currently enrolled in a Finance EMBA program at Tsinghua PBCSF \u6e05\u534e\u4e94\u9053\u53e3, which they are expected to complete in 2023, focusing on the Belt & Road Initiative.